Binding of both constructs to HCC1954 (HER2+CD3–) cancer cells and Jurkat (CD3+HER2–) cells was investigated by flow cytometry(three independent experiments in both cases, Figure 4/A). The gene discussed is ERBB2; the disease is cancer.